Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: A report from the Korean Breast Cancer Society

Journal of Clinical Oncology

Volumn 28, Issue 10, 2010, Pages 1692-1699

  Moon, Hyeong Gon ^a   Han, Wonshik ^a   Noh, Dong Young ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SOUTH KOREA; ASIAN; AXILLA; BREAST TUMOR; FEMALE; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; SURVIVAL; TUMOR RECURRENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; REGISTRIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 77950466501     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.9226     Document Type: Article

References (43)

1. Benson JR, della Rovere GQ: Management of the axilla in women with breast cancer. Lancet Oncol 8:331-348, 2007 (Pubitemid 46464531)
2. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005 (Pubitemid 46291835)
3. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-339, 1993
4. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398, 1994
5. Edge SB, Niland JC, Bookman MA, et al: Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 95:1514-1521, 2003 (Pubitemid 37322094)
6. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003 (Pubitemid 36951366)
7. Cody HS 3rd: Sentinel lymph node biopsy for breast cancer: Does anybody not need one? Ann Surg Oncol 10:1131-1132, 2003
8. Fisher B, Jeong JH, Anderson S, et al: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575, 2002
9. Zavagno G, De Salvo GL, Scalco G, et al: A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: Results of the Sentinella/GIVOM trial. Ann Surg 247:207-213, 2008 (Pubitemid 351156760)
10. Krag DN, Anderson SJ, Julian TB, et al: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888, 2007 (Pubitemid 47488052)
11. Canavese G, Catturich A, Vecchio C, et al: Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: Results of randomized trial. Ann Oncol 20:1001-1007, 2009
12. Henderson IC: Axillary surgery: Clinical judgment required. J Clin Oncol 24:325-326, 2006
13. Pater J, Parulekar W: Sentinel lymph node biopsy in early breast cancer: Has its time come? J Natl Cancer Inst 98:568-569, 2006 (Pubitemid 43904840)
14. Bland KI, Scott-Conner CE, Menck H, et al: Axillary dissection in breast-conserving surgery for stage I and II breast cancer: A National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188:586-595, 1999
15. Weir L, Speers C, D'yachkova Y, et al: Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20:1793-1799, 2002 (Pubitemid 34273268)
16. Krag DN, Single RM: Breast cancer survival according to number of nodes removed. Ann Surg Oncol 10:1152-1159, 2003 (Pubitemid 40486809)
17. Polednak AP: Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg 237:163-167, 2003
18. Axelsson CK, During M, Christiansen PM, et al: Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer. Br J Surg 96:40-46, 2009
19. Ahn SH, Son BH, Kim SW, et al: Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea - a report from the Korean Breast Cancer Society. J Clin Oncol 25:2360-2368, 2007
20. Jeong J: Korean Breast Cancer Society: Nationwide Korean breast cancer data of 2004 using breast cancer registration program. J Breast Cancer 9:151-161, 2006
21. Shin HR, Won YJ, Jung KW, et al: Nationwide cancer incidence in Korea, 1999-2001: First result using the National Cancer Incidence Database. Cancer Res Treat 37:325-331, 2005
22. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5:17-21, 1985 (Pubitemid 15163213)
23. Krag D: Why perform randomized clinical trials for sentinel node surgery for breast cancer? Am J Surg 182:411-413, 2001
24. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival: A Bayesian meta-analysis. Ann Surg Oncol 6:109-116, 1999
25. Martelli G, Boracchi P, De Palo M, et al: A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Ann Surg 242:1-6, 2005 (Pubitemid 40917960)
26. Rudenstam CM, Zahrieh D, Forbes JF, et al: Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 24:337-344, 2006 (Pubitemid 46630451)
27. Louis-Sylvestre C, Clough K, Asselain B, et al: Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22:97-101, 2004 (Pubitemid 41095119)
28. Sanghani M, Balk EM, Cady B: Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: A systematic review and meta-analysis. Cancer 115:1613-1620, 2009
29. Greco M, Agresti R, Cascinelli N, et al: Breast cancer patients treated without axillary surgery: Clinical implications and biologic analysis. Ann Surg 232:1-7, 2000 (Pubitemid 30456543)
30. Cady B: A contemporary view of axillary dissection. Ann Surg 232:8-9, 2000
31. Gupta GP, Massague J: Cancer metastasis: Building a framework. Cell 127:679-695, 2006 (Pubitemid 44781029)
32. Iyer RV, Hanlon A, Fowble B, et al: Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined. Int J Radiat Oncol Biol Phys 47:1177-1183, 2000 (Pubitemid 30421169)
33. Somner JE, Dixon JM, Thomas JS: Node retrieval in axillary lymph node dissections: Recommendations for minimum numbers to be confident about node negative status. J Clin Pathol 57:845-848, 2004 (Pubitemid 39061434)
34. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608, 1985 (Pubitemid 15062653)
35. Cufer T: Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! Online. Ann Oncol 19:vii41-45, 2008 (suppl 7)
36. Tjan-Heijnen VC, Buit P, de Widt-Evert LM, et al: Micro-metastases in axillary lymph nodes: An increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70:81-88, 2001 (Pubitemid 33139665)
37. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-399, 1995
38. Veronesi U, Galimberti V, Paganelli G, et al: Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases. Eur J Cancer 45:1381-1388, 2009
39. Smigal C, Jemal A, Ward E, et al: Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin 56:168-183, 2006
40. Vanderveen KA, Schneider PD, Khatri VP, et al: Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol 13:1450-1456, 2006 (Pubitemid 44749656)
41. Maaskant AJ, van de Poll-Franse LV, Voogd AC, et al: Stage migration due to introduction of the sentinel node procedure: A population-based study. Breast Cancer Res Treat 113:173-179, 2009
42. Purushotham AD, Upponi S, Klevesath MB, et al: Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 23:4312-4321, 2005 (Pubitemid 46209968)
43. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98:599-609, 2006 (Pubitemid 43904843)